Inflammatory Bowel Diseases  >>  NN9828  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NN9828 / Almirall
NCT01751152 / 2012-002432-93: A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Completed
2
53
US, Europe
NNC0114-0006, placebo
Novo Nordisk A/S
Inflammation, Crohn's Disease
12/14
12/14

Download Options